Pay in 4 interest-free payments of $5.87 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
After using this tool/service, the author(s) reviewed and edited the content as needed and take(s) full responsibility for the content of the publication
Integrity verifiable on receipt
Drmic, D., et al
Insurance companies typically restrict coverage to brand-name formulations like Ozempic or Mounjaro, which charge $900$1,400 monthly even with plan support
GLP-1 receptor agonists mimic endogenous GLP-1 activity and are currently approved for the treatment of obesity and type 2 diabetes mellitus
The cost differential is the primary reason 100,000+ patients have enrolled in compounded GLP-1 programs - it makes access to this drug class practically achievable for people who can't get insurance coverage or afford brand pricing
US$ 23.22
US$ 23.33
US$ 21.69
US$ 29.82
